David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

William Valente is an Endocrinologist in Baltimore, Maryland. Dr. Valente is rated as a Distinguished provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Graves Disease, Thyroid Storm, Toxic Nodular Goiter, and Thyroid Nodule.

Ashley A. Campbell M.D., is an associate professor in the division of oculoplastics at the Wilmer Eye Institute, Johns Hopkins Medicine. After receiving her medical degree at the Johns Hopkins University School of Medicine, she completed her ophthalmology residency at the Massachusetts Eye and Ear Infirmary (Harvard Medical School). She then completed additional specialty training as an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) fellow at Columbia, Cornell, New York University, and Manhattan Eye Ear and Throat Hospital. Dr. Campbell’s clinical interests include reconstructive and cosmetic surgery of the eyelid and periorbital area, management of tear drainage issues, Mohs reconstruction, eyelid and orbital tumors, orbital surgery, orbital trauma, thyroid eye disease, and facial rejuvenation. Dr. Campbell is rated as an Advanced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Thyroid Eye Disease, Chalazion, Graves Disease, and Entropion.

Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as an Advanced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as an Advanced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Advanced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Jennifer Mammen, M.D., Ph.D., Assistant Professor of Medicine, is a member the Division of Endocrinology, Diabetes and Metabolism. Dr. Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is actively engaged in research on hormonal function and aging. Dr. Mammen is rated as an Advanced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Hyperthyroidism, Hypothyroidism, Thyroid Storm, Graves Disease, and Hormone Replacement Therapy (HRT).

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Experienced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.

Dr. Henderson is the Frank B. Walsh Professor of Neuro-Ophthalmology at the Wilmer Eye Institute and is the Chief of the Wilmer Neuro-Ophthalmology Division. She attended medical school at Emory University, completed an ophthalmology residency at the Medical College of Georgia, and completed a fellowship in neuro-ophthalmology at the Bascom Palmer Eye Institute. Her research interests include optic neuropathies, specifically non-arteritic anterior ischemic optic neuropathy; high-value care; and the use of big data to answer neuro-ophthalmic questions. She also has a particular interest in medical education and serves as the Associate Ophthalmology Residency Program Director and the Neuro-Ophthalmology Fellowship Director. Dr. Henderson is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Optic Neuritis, Strabismus, Increased Intracranial Pressure, and Optic Atrophy Type 1.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Experienced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Sophia Ali is an Endocrinologist in Baltimore, Maryland. Dr. Ali is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Prolactinoma, Hyperthyroidism, Pituitary Tumor, Graves Disease, and Thyroidectomy.

Neil R. Miller, M.D., is Professor of Ophthalmology, Neurology & Neurosurgery. He specializes in neuro-ophthalmology and orbital disease. Dr. Miller received his M.D. degree from the Johns Hopkins University School of Medicine and completed his residency in ophthalmology at the Wilmer Eye Institute, where he also served as chief resident. He completed a fellowship in neuro-ophthalmology at the University of CA, San Francisco. He has been a member of the Wilmer faculty since 1976. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Increased Intracranial Pressure, Benign Essential Blepharospasm, Papilledema, Vitrectomy, and Cataract Removal.

Shadi Barakat is an Endocrinologist in Baltimore, Maryland. Dr. Barakat has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Type 2 Diabetes (T2D), Toxic Nodular Goiter, Thyroid Cancer, and Thyroid Storm.

An associate professor of medicine, and the L. Douglas Lee and Barbara Levinson-Lee Professorship in Clinical Practice, Steven J. Kravet, M.D., M.B.A., serves as president of the largest primary care group in Maryland, Johns Hopkins Community Physicians; a network of suburban community practices that serves more than 900,000 patients annually at more than 40 locations throughout Maryland, Washington, D.C., and Northern Virginia. A third-generation pharmacist and community health care advocate who prizes the relationships that develop between patients and care-givers, Dr. Kravet has spent more than two decades at Johns Hopkins Bayview Medical Center, providing strong leadership in a wide variety of community health services. Before being named president of Johns Hopkins Community Physicians in 2009, Dr. Kravet served as medical director of inpatient medical services, internal medicine and ambulatory services, as well as chief medical officer for quality and patient safety, and deputy director for clinical activity in the Department of Medicine at Johns Hopkins Bayview Medical Center. As a member of the faculty in the Division of General Internal Medicine, he has obtained invaluable insights into the practical realities of primary care. Having earned an M.B.A. in Johns Hopkins’ Business of Medicine program, he has an excellent understanding of the business issues affecting outpatient care. The American College of Physicians has used Dr. Kravet’s research on primary care processes to formulate plans for redesigning health care practices. After receiving his pharmacist degree from the Rutgers University College of Pharmacy in 1988, Dr. Kravet ran his family’s pharmacy in Spotswood, N.J., until 1992, during which time he worked on obtaining his medical degree from the Robert Wood Johnson Medical School. He arrived at Johns Hopkins Bayview as a resident in 1992 and has spent his entire career at Johns Hopkins. Among his honors are the Resident Teaching Award and the Department of Medicine Chairman’s Award. Dr. Kravet practices all aspects of primary care medicine, including prevention and cortisone shots. Dr. Kravet is rated as an Experienced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Tinea Versicolor.

Usiwoma Abugo is an Ophthalmologist in Baltimore, Maryland. Dr. Abugo is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Chalazion, Eyelid Bump, Meibomianitis, and Entropion. Dr. Abugo is currently accepting new patients.

Marie Bellantoni is an Endocrinologist in Baltimore, Maryland. Dr. Bellantoni is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Parathyroid Cancer, and Thyroid Nodule.

Babette Glister is an Endocrinologist in Baltimore, Maryland. Dr. Glister is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Medullary Thyroid Carcinoma, Papillary Thyroid Cancer, Thyroid Cancer, and Follicular Thyroid Cancer.

Samuel Friedel is an Ophthalmologist in Baltimore, Maryland. Dr. Friedel is rated as an Experienced provider by MediFind in the treatment of Graves Disease. His top areas of expertise are Glaucoma, Cataract, Diabetic Retinopathy, and Dry Eye Syndrome. Dr. Friedel is currently accepting new patients.

Moran Levin is an Ophthalmologist in Baltimore, Maryland. Dr. Levin is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Strabismus, Amblyopia, Esotropia, and Isolated Duane Retraction Syndrome. Dr. Levin is currently accepting new patients.

Rana Malek is an Endocrinologist in Baltimore, Maryland. Dr. Malek is rated as an Experienced provider by MediFind in the treatment of Graves Disease. Her top areas of expertise are Type 2 Diabetes (T2D), Addison's Disease, Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroidectomy.